APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical Microbiology Testing

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Pharmaceutical Microbiology Testing Market Analysis and Forecast 2026-2032

4 June 2026223 pages

Choose your research edition.

Industry ResearchPharmaceutical Microbiology Testing Industry Research Report 2026141 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical Microbiology Testing Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Pharmaceutical Microbiology Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical Microbiology Testing Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical Microbiology Testing Market Analysis and Forecast 2026-2032223 pages · $4,950 USD

Market perspective

The global Pharmaceutical Microbiology Testing market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Pharmaceutical Microbiology Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Pharmaceutical Microbiology Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Pharmaceutical Microbiology Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Pharmaceutical Microbiology Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Pharmaceutical Microbiology Testing include Eurofins Scientific, Charles River Laboratories, SGS, WuXi AppTec, Nelson Labs, Pace Analytical, Thermo Fisher Scientific, Merck KGaA / MilliporeSigma and bioMérieux, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Pharmaceutical Microbiology Testing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pharmaceutical Microbiology Testing, also provides the revenue of main regions and countries. Of the upcoming market potential for Pharmaceutical Microbiology Testing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pharmaceutical Microbiology Testing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pharmaceutical Microbiology Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Pharmaceutical Microbiology Testing revenue, projected growth trends, production technology, application and end-user industry.

Pharmaceutical Microbiology Testing Segment by Company

Eurofins Scientific

Charles River Laboratories

SGS

WuXi AppTec

Nelson Labs

Pace Analytical

Thermo Fisher Scientific

Merck KGaA / MilliporeSigma

bioMérieux

Sartorius

STERIS

Intertek

ALS Limited

Microbac Laboratories

Alcami

Almac Group

Labcorp Drug Development

Element Materials Technology

Toxikon

Aurigene Pharmaceutical Services

Toray Research Center

Centre Testing International Group

Pony Testing International Group

Sumika Chemical Analysis Service

CMIC Group

LSI Medience

Pharmaceutical Microbiology Testing Segment by Type

Culture-Based Testing

Rapid Microbial Testing

Molecular Testing

Automated Microbiology Testing

Others

Pharmaceutical Microbiology Testing Segment by Application

Pharmaceutical Industry

CRO/CDMO

Medical Device

Others

Pharmaceutical Microbiology Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Microbiology Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Microbiology Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Microbiology Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Pharmaceutical Microbiology Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Pharmaceutical Microbiology Testing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmaceutical Microbiology Testing revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pharmaceutical Microbiology Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Culture-Based Testing Major Player Table 3. Rapid Microbial Testing Major Player Table 4. Molecular Testing Major Player Table 5. Automated Microbiology Testing Major Player Table 6. Others Major Player Table 7. Global Pharmaceutical Microbiology Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Pharmaceutical Industry Major Player Table 9. CRO/CDMO Major Player Table 10. Medical Device Major Player Table 11. Others Major Player Table 12. Pharmaceutical Microbiology Testing Industry Trends Table 13. Pharmaceutical Microbiology Testing Industry Drivers Table 14. Pharmaceutical Microbiology Testing Industry Opportunities and Challenges Table 15. Pharmaceutical Microbiology Testing Industry Restraints Table 16. Global Pharmaceutical Microbiology Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 17. Global Pharmaceutical Microbiology Testing Market Size by Region (2021-2026) & (US$ Million) Table 18. Global Pharmaceutical Microbiology Testing Market Share by Region (2021-2026) Table 19. Global Pharmaceutical Microbiology Testing Market Size by Region (2027-2032) & (US$ Million) Table 20. Global Pharmaceutical Microbiology Testing Market Share by Region (2027-2032) Table 21. Global Pharmaceutical Microbiology Testing Revenue by Players (US$ Million) & (2021-2026) Table 22. Global Pharmaceutical Microbiology Testing Revenue Market Share by Players (2021-2026) Table 23. Global Pharmaceutical Microbiology Testing Key Players Ranking, 2024 VS 2025 VS 2026 Table 24. Global Pharmaceutical Microbiology Testing Key Players Headquarters & Area Served Table 25. Global Pharmaceutical Microbiology Testing Players, Product Type & Application Table 26. Global Pharmaceutical Microbiology Testing Players Establishment Date Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Pharmaceutical Microbiology Testing by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Global Pharmaceutical Microbiology Testing Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Pharmaceutical Microbiology Testing Revenue by Type (2021-2026) & (US$ Million) Table 31. Global Pharmaceutical Microbiology Testing Revenue by Type (2027-2032) & (US$ Million) Table 32. Global Pharmaceutical Microbiology Testing Revenue Market Share by Type (2021-2026) Table 33. Global Pharmaceutical Microbiology Testing Revenue Market Share by Type (2027-2032) Table 34. Global Pharmaceutical Microbiology Testing Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Pharmaceutical Microbiology Testing Revenue by Application (2021-2026) & (US$ Million) Table 36. Global Pharmaceutical Microbiology Testing Revenue by Application (2027-2032) & (US$ Million) Table 37. Global Pharmaceutical Microbiology Testing Revenue Market Share by Application (2021-2026) Table 38. Global Pharmaceutical Microbiology Testing Revenue Market Share by Application (2027-2032) Table 39. Eurofins Scientific Company Information Table 40. Eurofins Scientific Business Overview Table 41. Eurofins Scientific Pharmaceutical Microbiology Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Eurofins Scientific Pharmaceutical Microbiology Testing Product Portfolio Table 43. Eurofins Scientific Recent Development Table 44. Charles River Laboratories Company Information Table 45. Charles River Laboratories Business Overview Table 46. Charles River Laboratories Pharmaceutical Microbiology Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Charles River Laboratories Pharmaceutical Microbiology Testing Product Portfolio Table 48. Charles River Laboratories Recent Development Table 49. SGS Company Information Table 50. SGS Business Overview Table 51. SGS Pharmaceutical Microbiology Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. SGS Pharmaceutical Microbiology Testing Product Portfolio Table 53. SGS Recent Development Table 54. WuXi AppTec Company Information Table 55. WuXi AppTec Business Overview Table 56. WuXi AppTec Pharmaceutical Microbiology Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. WuXi AppTec Pharmaceutical Microbiology Testing Product Portfolio Table 58. WuXi AppTec Recent Development Table 59. Nelson Labs Company Information Table 60. Nelson Labs Business Overview Table 61. Nelson Labs Pharmaceutical Microbiology Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Nelson Labs Pharmaceutical Microbiology Testing Product Portfolio Table 63. Nelson Labs Recent Development Table 64. Pace Analytical Company Information Table 65. Pace Analytical Business Overview Table 66. Pace Analytical Pharmaceutical Microbiology Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Pace Analytical Pharmaceutical Microbiology Testing Product Portfolio Table 68. Pace Analytical Recent Development Table 69. Thermo Fisher Scientific Company Information Table 70. Thermo Fisher Scientific Business Overview Table 71. Thermo Fisher Scientific Pharmaceutical Microbiology Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Thermo Fisher Scientific Pharmaceutical Microbiology Testing Product Portfolio Table 73. Thermo Fisher Scientific Recent Development Table 74. Merck KGaA / MilliporeSigma Company Information Table 75. Merck KGaA / MilliporeSigma Business Overview Table 76. Merck KGaA / MilliporeSigma Pharmaceutical Microbiology Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Merck KGaA / MilliporeSigma Pharmaceutical Microbiology Testing Product Portfolio Table 78. Merck KGaA / MilliporeSigma Recent Development Table 79. bioMérieux Company Information Table 80. bioMérieux Business Overview Table 81. bioMérieux Pharmaceutical Microbiology Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. bioMérieux Pharmaceutical Microbiology Testing Product Portfolio Table 83. bioMérieux Recent Development Table 84. Sartorius Company Information Table 85. Sartorius Business Overview Table 86. Sartorius Pharmaceutical Microbiology Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Sartorius Pharmaceutical Microbiology Testing Product Portfolio Table 88. Sartorius Recent Development Table 89. STERIS Company Information Table 90. STERIS Business Overview Table 91. STERIS Pharmaceutical Microbiology Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. STERIS Pharmaceutical Microbiology Testing Product Portfolio Table 93. STERIS Recent Development Table 94. Intertek Company Information Table 95. Intertek Business Overview Table 96. Intertek Pharmaceutical Microbiology Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Intertek Pharmaceutical Microbiology Testing Product Portfolio Table 98. Intertek Recent Development Table 99. ALS Limited Company Information Table 100. ALS Limited Business Overview Table 101. ALS Limited Pharmaceutical Microbiology Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. ALS Limited Pharmaceutical Microbiology Testing Product Portfolio Table 103. ALS Limited Recent Development Table 104. Microbac Laboratories Company Information Table 105. Microbac Laboratories Business Overview Table 106. Microbac Laboratories Pharmaceutical Microbiology Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. Microbac Laboratories Pharmaceutical Microbiology Testing Product Portfolio Table 108. Microbac Laboratories Recent Development Table 109. Alcami Company Information Table 110. Alcami Business Overview Table 111. Alcami Pharmaceutical Microbiology Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. Alcami Pharmaceutical Microbiology Testing Product Portfolio Table 113. Alcami Recent Development Table 114. Almac Group Company Information Table 115. Almac Group Business Overview Table 116. Almac Group Pharmaceutical Microbiology Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. Almac Group Pharmaceutical Microbiology Testing Product Portfolio Table 118. Almac Group Recent Development Table 119. Labcorp Drug Development Company Information Table 120. Labcorp Drug Development Business Overview Table 121. Labcorp Drug Development Pharmaceutical Microbiology Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 122. Labcorp Drug Development Pharmaceutical Microbiology Testing Product Portfolio Table 123. Labcorp Drug Development Recent Development Table 124. Element Materials Technology Company Information Table 125. Element Materials Technology Business Overview Table 126. Element Materials Technology Pharmaceutical Microbiology Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 127. Element Materials Technology Pharmaceutical Microbiology Testing Product Portfolio Table 128. Element Materials Technology Recent Development Table 129. Toxikon Company Information Table 130. Toxikon Business Overview Table 131. Toxikon Pharmaceutical Microbiology Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 132. Toxikon Pharmaceutical Microbiology Testing Product Portfolio Table 133. Toxikon Recent Development Table 134. Aurigene Pharmaceutical Services Company Information Table 135. Aurigene Pharmaceutical Services Business Overview Table 136. Aurigene Pharmaceutical Services Pharmaceutical Microbiology Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 137. Aurigene Pharmaceutical Services Pharmaceutical Microbiology Testing Product Portfolio Table 138. Aurigene Pharmaceutical Services Recent Development Table 139. Toray Research Center Company Information Table 140. Toray Research Center Business Overview Table 141. Toray Research Center Pharmaceutical Microbiology Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 142. Toray Research Center Pharmaceutical Microbiology Testing Product Portfolio Table 143. Toray Research Center Recent Development Table 144. Centre Testing International Group Company Information Table 145. Centre Testing International Group Business Overview Table 146. Centre Testing International Group Pharmaceutical Microbiology Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 147. Centre Testing International Group Pharmaceutical Microbiology Testing Product Portfolio Table 148. Centre Testing International Group Recent Development Table 149. Pony Testing International Group Company Information Table 150. Pony Testing International Group Business Overview Table 151. Pony Testing International Group Pharmaceutical Microbiology Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 152. Pony Testing International Group Pharmaceutical Microbiology Testing Product Portfolio Table 153. Pony Testing International Group Recent Development Table 154. Sumika Chemical Analysis Service Company Information Table 155. Sumika Chemical Analysis Service Business Overview Table 156. Sumika Chemical Analysis Service Pharmaceutical Microbiology Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 157. Sumika Chemical Analysis Service Pharmaceutical Microbiology Testing Product Portfolio Table 158. Sumika Chemical Analysis Service Recent Development Table 159. CMIC Group Company Information Table 160. CMIC Group Business Overview Table 161. CMIC Group Pharmaceutical Microbiology Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 162. CMIC Group Pharmaceutical Microbiology Testing Product Portfolio Table 163. CMIC Group Recent Development Table 164. LSI Medience Company Information Table 165. LSI Medience Business Overview Table 166. LSI Medience Pharmaceutical Microbiology Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 167. LSI Medience Pharmaceutical Microbiology Testing Product Portfolio Table 168. LSI Medience Recent Development Table 169. North America Pharmaceutical Microbiology Testing Revenue by Type (2021-2026) & (US$ Million) Table 170. North America Pharmaceutical Microbiology Testing Revenue by Type (2027-2032) & (US$ Million) Table 171. North America Pharmaceutical Microbiology Testing Revenue by Application (2021-2026) & (US$ Million) Table 172. North America Pharmaceutical Microbiology Testing Revenue by Application (2027-2032) & (US$ Million) Table 173. North America Pharmaceutical Microbiology Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 174. North America Pharmaceutical Microbiology Testing Revenue by Country (2021-2026) & (US$ Million) Table 175. North America Pharmaceutical Microbiology Testing Revenue by Country (US$ Million) & (2027-2032) Table 176. Europe Pharmaceutical Microbiology Testing Revenue by Type (2021-2026) & (US$ Million) Table 177. Europe Pharmaceutical Microbiology Testing Revenue by Type (2027-2032) & (US$ Million) Table 178. Europe Pharmaceutical Microbiology Testing Revenue by Application (2021-2026) & (US$ Million) Table 179. Europe Pharmaceutical Microbiology Testing Revenue by Application (2027-2032) & (US$ Million) Table 180. Europe Pharmaceutical Microbiology Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 181. Europe Pharmaceutical Microbiology Testing Revenue by Country (2021-2026) & (US$ Million) Table 182. Europe Pharmaceutical Microbiology Testing Revenue by Country (US$ Million) & (2027-2032) Table 183. China Pharmaceutical Microbiology Testing Revenue by Type (2021-2026) & (US$ Million) Table 184. China Pharmaceutical Microbiology Testing Revenue by Type (2027-2032) & (US$ Million) Table 185. China Pharmaceutical Microbiology Testing Revenue by Application (2021-2026) & (US$ Million) Table 186. China Pharmaceutical Microbiology Testing Revenue by Application (2027-2032) & (US$ Million) Table 187. Asia Pharmaceutical Microbiology Testing Revenue by Type (2021-2026) & (US$ Million) Table 188. Asia Pharmaceutical Microbiology Testing Revenue by Type (2027-2032) & (US$ Million) Table 189. Asia Pharmaceutical Microbiology Testing Revenue by Application (2021-2026) & (US$ Million) Table 190. Asia Pharmaceutical Microbiology Testing Revenue by Application (2027-2032) & (US$ Million) Table 191. Asia Pharmaceutical Microbiology Testing Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 192. Asia Pharmaceutical Microbiology Testing Revenue by Region (US$ Million) & (2021-2026) Table 193. Asia Pharmaceutical Microbiology Testing Revenue by Region (US$ Million) & (2027-2032) Table 194. SAMEA Pharmaceutical Microbiology Testing Revenue by Type (2021-2026) & (US$ Million) Table 195. SAMEA Pharmaceutical Microbiology Testing Revenue by Type (2027-2032) & (US$ Million) Table 196. SAMEA Pharmaceutical Microbiology Testing Revenue by Application (2021-2026) & (US$ Million) Table 197. SAMEA Pharmaceutical Microbiology Testing Revenue by Application (2027-2032) & (US$ Million) Table 198. SAMEA Pharmaceutical Microbiology Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 199. SAMEA Pharmaceutical Microbiology Testing Revenue by Country (2021-2026) & (US$ Million) Table 200. SAMEA Pharmaceutical Microbiology Testing Revenue by Country (US$ Million) & (2027-2032) Table 201. Research Programs/Design for This Report Table 202. Authors List of This Report Table 203. Secondary Sources Table 204. Primary Sources List of Figures Figure 1. Pharmaceutical Microbiology Testing Image Figure 2. Global Pharmaceutical Microbiology Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmaceutical Microbiology Testing Market Size Share 2021 VS 2025 VS 2032 Figure 4. Culture-Based Testing Image Figure 5. Rapid Microbial Testing Image Figure 6. Molecular Testing Image Figure 7. Automated Microbiology Testing Image Figure 8. Others Image Figure 9. Global Pharmaceutical Microbiology Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Pharmaceutical Microbiology Testing Market Size Share 2021 VS 2025 VS 2032 Figure 11. Pharmaceutical Industry Image Figure 12. CRO/CDMO Image Figure 13. Medical Device Image Figure 14. Others Image Figure 15. Global Pharmaceutical Microbiology Testing Market Size (US$ Million) & (2021-2032) Figure 16. Global Pharmaceutical Microbiology Testing Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Pharmaceutical Microbiology Testing Market Share by Region: 2021 VS 2025 VS 2032 Figure 18. Global Pharmaceutical Microbiology Testing Players Revenue Share Top 10 and Top 5 in 2025 Figure 19. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Pharmaceutical Microbiology Testing Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Pharmaceutical Microbiology Testing Revenue Market Share 2021 VS 2025 VS 2032 Figure 22. Global Pharmaceutical Microbiology Testing Revenue Market Share by Type (2021-2032) Figure 23. Global Pharmaceutical Microbiology Testing Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Pharmaceutical Microbiology Testing Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 25. Global Pharmaceutical Microbiology Testing Revenue Market Share by Application (2021-2032) Figure 26. North America Pharmaceutical Microbiology Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 27. North America Pharmaceutical Microbiology Testing Revenue Share by Type (2021-2032) Figure 28. North America Pharmaceutical Microbiology Testing Revenue Share by Application (2021-2032) Figure 29. North America Pharmaceutical Microbiology Testing Revenue Share by Country (2021-2032) Figure 30. United States Pharmaceutical Microbiology Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Canada Pharmaceutical Microbiology Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Mexico Pharmaceutical Microbiology Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Europe Pharmaceutical Microbiology Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 34. Europe Pharmaceutical Microbiology Testing Revenue Share by Type (2021-2032) Figure 35. Europe Pharmaceutical Microbiology Testing Revenue Share by Application (2021-2032) Figure 36. Europe Pharmaceutical Microbiology Testing Revenue Share by Country (2021-2032) Figure 37. Germany Pharmaceutical Microbiology Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. France Pharmaceutical Microbiology Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. U.K. Pharmaceutical Microbiology Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Italy Pharmaceutical Microbiology Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Spain Pharmaceutical Microbiology Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Russia Pharmaceutical Microbiology Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Netherlands Pharmaceutical Microbiology Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Nordic Countries Pharmaceutical Microbiology Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. China Pharmaceutical Microbiology Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. China Pharmaceutical Microbiology Testing Revenue Share by Type (2021-2032) Figure 47. China Pharmaceutical Microbiology Testing Revenue Share by Application (2021-2032) Figure 48. Asia Pharmaceutical Microbiology Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 49. Asia Pharmaceutical Microbiology Testing Revenue Share by Type (2021-2032) Figure 50. Asia Pharmaceutical Microbiology Testing Revenue Share by Application (2021-2032) Figure 51. Asia Pharmaceutical Microbiology Testing Revenue Share by Region (2021-2032) Figure 52. Japan Pharmaceutical Microbiology Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. South Korea Pharmaceutical Microbiology Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. India Pharmaceutical Microbiology Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Australia Pharmaceutical Microbiology Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Taiwan Pharmaceutical Microbiology Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Southeast Asia Pharmaceutical Microbiology Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. SAMEA Pharmaceutical Microbiology Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 59. SAMEA Pharmaceutical Microbiology Testing Revenue Share by Type (2021-2032) Figure 60. SAMEA Pharmaceutical Microbiology Testing Revenue Share by Application (2021-2032) Figure 61. SAMEA Pharmaceutical Microbiology Testing Revenue Share by Country (2021-2032) Figure 62. Brazil Pharmaceutical Microbiology Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Argentina Pharmaceutical Microbiology Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Chile Pharmaceutical Microbiology Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Colombia Pharmaceutical Microbiology Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Peru Pharmaceutical Microbiology Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Saudi Arabia Pharmaceutical Microbiology Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Israel Pharmaceutical Microbiology Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. UAE Pharmaceutical Microbiology Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Turkey Pharmaceutical Microbiology Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Iran Pharmaceutical Microbiology Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Egypt Pharmaceutical Microbiology Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Culture-Based Testing
  • Rapid Microbial Testing
  • Molecular Testing
  • Automated Microbiology Testing
  • Others
Applications
  • Pharmaceutical Industry
  • CRO/CDMO
  • Medical Device
  • Others
Companies covered
  • Eurofins Scientific
  • Charles River Laboratories
  • SGS
  • WuXi AppTec
  • Nelson Labs
  • Pace Analytical
  • Thermo Fisher Scientific
  • Merck KGaA / MilliporeSigma
  • bioMérieux
  • Sartorius
  • STERIS
  • Intertek
  • ALS Limited
  • Microbac Laboratories
  • Alcami
  • Almac Group
  • Labcorp Drug Development
  • Element Materials Technology
  • Toxikon
  • Aurigene Pharmaceutical Services
  • Toray Research Center
  • Centre Testing International Group
  • Pony Testing International Group
  • Sumika Chemical Analysis Service
  • CMIC Group
  • LSI Medience

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pharmaceutical Microbiology Testing Market by Type
  3. 1.2.1 Global Pharmaceutical Microbiology Testing Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Culture-Based Testing
  5. 1.2.3 Rapid Microbial Testing
  6. 1.2.4 Molecular Testing
  7. 1.2.5 Automated Microbiology Testing
  8. 1.2.6 Others
  9. 1.3 Pharmaceutical Microbiology Testing Market by Application
  10. 1.3.1 Global Pharmaceutical Microbiology Testing Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Pharmaceutical Industry
  12. 1.3.3 CRO/CDMO
  13. 1.3.4 Medical Device
  14. 1.3.5 Others
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Pharmaceutical Microbiology Testing Market Dynamics
  1. 2.1 Pharmaceutical Microbiology Testing Industry Trends
  2. 2.2 Pharmaceutical Microbiology Testing Industry Drivers
  3. 2.3 Pharmaceutical Microbiology Testing Industry Opportunities and Challenges
  4. 2.4 Pharmaceutical Microbiology Testing Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Pharmaceutical Microbiology Testing Market Perspective (2021-2032)
  2. 3.2 Global Pharmaceutical Microbiology Testing Growth Trends by Region
  3. 3.2.1 Global Pharmaceutical Microbiology Testing Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pharmaceutical Microbiology Testing Market Size by Region (2021-2026)
  5. 3.2.3 Global Pharmaceutical Microbiology Testing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Pharmaceutical Microbiology Testing Revenue by Players
  2. 4.1.1 Global Pharmaceutical Microbiology Testing Revenue by Players (2021-2026)
  3. 4.1.2 Global Pharmaceutical Microbiology Testing Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Pharmaceutical Microbiology Testing Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pharmaceutical Microbiology Testing Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Pharmaceutical Microbiology Testing Key Players Headquarters & Area Served
  7. 4.4 Global Pharmaceutical Microbiology Testing Players, Product Type & Application
  8. 4.5 Global Pharmaceutical Microbiology Testing Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Pharmaceutical Microbiology Testing Market CR5 and HHI
  11. 4.6.3 2025 Pharmaceutical Microbiology Testing Tier 1, Tier 2, and Tier 3
5 Pharmaceutical Microbiology Testing Market Size by Type
  1. 5.1 Global Pharmaceutical Microbiology Testing Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Pharmaceutical Microbiology Testing Revenue by Type (2021-2032)
  3. 5.3 Global Pharmaceutical Microbiology Testing Revenue Market Share by Type (2021-2032)
6 Pharmaceutical Microbiology Testing Market Size by Application
  1. 6.1 Global Pharmaceutical Microbiology Testing Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Pharmaceutical Microbiology Testing Revenue by Application (2021-2032)
  3. 6.3 Global Pharmaceutical Microbiology Testing Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Eurofins Scientific
  2. 7.1.1 Eurofins Scientific Company Information
  3. 7.1.2 Eurofins Scientific Business Overview
  4. 7.1.3 Eurofins Scientific Pharmaceutical Microbiology Testing Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Eurofins Scientific Pharmaceutical Microbiology Testing Product Portfolio
  6. 7.1.5 Eurofins Scientific Recent Developments
  7. 7.2 Charles River Laboratories
  8. 7.2.1 Charles River Laboratories Company Information
  9. 7.2.2 Charles River Laboratories Business Overview
  10. 7.2.3 Charles River Laboratories Pharmaceutical Microbiology Testing Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Charles River Laboratories Pharmaceutical Microbiology Testing Product Portfolio
  12. 7.2.5 Charles River Laboratories Recent Developments
  13. 7.3 SGS
  14. 7.3.1 SGS Company Information
  15. 7.3.2 SGS Business Overview
  16. 7.3.3 SGS Pharmaceutical Microbiology Testing Revenue and Gross Margin (2021-2026)
  17. 7.3.4 SGS Pharmaceutical Microbiology Testing Product Portfolio
  18. 7.3.5 SGS Recent Developments
  19. 7.4 WuXi AppTec
  20. 7.4.1 WuXi AppTec Company Information
  21. 7.4.2 WuXi AppTec Business Overview
  22. 7.4.3 WuXi AppTec Pharmaceutical Microbiology Testing Revenue and Gross Margin (2021-2026)
  23. 7.4.4 WuXi AppTec Pharmaceutical Microbiology Testing Product Portfolio
  24. 7.4.5 WuXi AppTec Recent Developments
  25. 7.5 Nelson Labs
  26. 7.5.1 Nelson Labs Company Information
  27. 7.5.2 Nelson Labs Business Overview
  28. 7.5.3 Nelson Labs Pharmaceutical Microbiology Testing Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Nelson Labs Pharmaceutical Microbiology Testing Product Portfolio
  30. 7.5.5 Nelson Labs Recent Developments
  31. 7.6 Pace Analytical
  32. 7.6.1 Pace Analytical Company Information
  33. 7.6.2 Pace Analytical Business Overview
  34. 7.6.3 Pace Analytical Pharmaceutical Microbiology Testing Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Pace Analytical Pharmaceutical Microbiology Testing Product Portfolio
  36. 7.6.5 Pace Analytical Recent Developments
  37. 7.7 Thermo Fisher Scientific
  38. 7.7.1 Thermo Fisher Scientific Company Information
  39. 7.7.2 Thermo Fisher Scientific Business Overview
  40. 7.7.3 Thermo Fisher Scientific Pharmaceutical Microbiology Testing Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Thermo Fisher Scientific Pharmaceutical Microbiology Testing Product Portfolio
  42. 7.7.5 Thermo Fisher Scientific Recent Developments
  43. 7.8 Merck KGaA / MilliporeSigma
  44. 7.8.1 Merck KGaA / MilliporeSigma Company Information
  45. 7.8.2 Merck KGaA / MilliporeSigma Business Overview
  46. 7.8.3 Merck KGaA / MilliporeSigma Pharmaceutical Microbiology Testing Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Merck KGaA / MilliporeSigma Pharmaceutical Microbiology Testing Product Portfolio
  48. 7.8.5 Merck KGaA / MilliporeSigma Recent Developments
  49. 7.9 bioMérieux
  50. 7.9.1 bioMérieux Company Information
  51. 7.9.2 bioMérieux Business Overview
  52. 7.9.3 bioMérieux Pharmaceutical Microbiology Testing Revenue and Gross Margin (2021-2026)
  53. 7.9.4 bioMérieux Pharmaceutical Microbiology Testing Product Portfolio
  54. 7.9.5 bioMérieux Recent Developments
  55. 7.10 Sartorius
  56. 7.10.1 Sartorius Company Information
  57. 7.10.2 Sartorius Business Overview
  58. 7.10.3 Sartorius Pharmaceutical Microbiology Testing Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Sartorius Pharmaceutical Microbiology Testing Product Portfolio
  60. 7.10.5 Sartorius Recent Developments
  61. 7.11 STERIS
  62. 7.11.1 STERIS Company Information
  63. 7.11.2 STERIS Business Overview
  64. 7.11.3 STERIS Pharmaceutical Microbiology Testing Revenue and Gross Margin (2021-2026)
  65. 7.11.4 STERIS Pharmaceutical Microbiology Testing Product Portfolio
  66. 7.11.5 STERIS Recent Developments
  67. 7.12 Intertek
  68. 7.12.1 Intertek Company Information
  69. 7.12.2 Intertek Business Overview
  70. 7.12.3 Intertek Pharmaceutical Microbiology Testing Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Intertek Pharmaceutical Microbiology Testing Product Portfolio
  72. 7.12.5 Intertek Recent Developments
  73. 7.13 ALS Limited
  74. 7.13.1 ALS Limited Company Information
  75. 7.13.2 ALS Limited Business Overview
  76. 7.13.3 ALS Limited Pharmaceutical Microbiology Testing Revenue and Gross Margin (2021-2026)
  77. 7.13.4 ALS Limited Pharmaceutical Microbiology Testing Product Portfolio
  78. 7.13.5 ALS Limited Recent Developments
  79. 7.14 Microbac Laboratories
  80. 7.14.1 Microbac Laboratories Company Information
  81. 7.14.2 Microbac Laboratories Business Overview
  82. 7.14.3 Microbac Laboratories Pharmaceutical Microbiology Testing Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Microbac Laboratories Pharmaceutical Microbiology Testing Product Portfolio
  84. 7.14.5 Microbac Laboratories Recent Developments
  85. 7.15 Alcami
  86. 7.15.1 Alcami Company Information
  87. 7.15.2 Alcami Business Overview
  88. 7.15.3 Alcami Pharmaceutical Microbiology Testing Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Alcami Pharmaceutical Microbiology Testing Product Portfolio
  90. 7.15.5 Alcami Recent Developments
  91. 7.16 Almac Group
  92. 7.16.1 Almac Group Company Information
  93. 7.16.2 Almac Group Business Overview
  94. 7.16.3 Almac Group Pharmaceutical Microbiology Testing Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Almac Group Pharmaceutical Microbiology Testing Product Portfolio
  96. 7.16.5 Almac Group Recent Developments
  97. 7.17 Labcorp Drug Development
  98. 7.17.1 Labcorp Drug Development Company Information
  99. 7.17.2 Labcorp Drug Development Business Overview
  100. 7.17.3 Labcorp Drug Development Pharmaceutical Microbiology Testing Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Labcorp Drug Development Pharmaceutical Microbiology Testing Product Portfolio
  102. 7.17.5 Labcorp Drug Development Recent Developments
  103. 7.18 Element Materials Technology
  104. 7.18.1 Element Materials Technology Company Information
  105. 7.18.2 Element Materials Technology Business Overview
  106. 7.18.3 Element Materials Technology Pharmaceutical Microbiology Testing Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Element Materials Technology Pharmaceutical Microbiology Testing Product Portfolio
  108. 7.18.5 Element Materials Technology Recent Developments
  109. 7.19 Toxikon
  110. 7.19.1 Toxikon Company Information
  111. 7.19.2 Toxikon Business Overview
  112. 7.19.3 Toxikon Pharmaceutical Microbiology Testing Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Toxikon Pharmaceutical Microbiology Testing Product Portfolio
  114. 7.19.5 Toxikon Recent Developments
  115. 7.20 Aurigene Pharmaceutical Services
  116. 7.20.1 Aurigene Pharmaceutical Services Company Information
  117. 7.20.2 Aurigene Pharmaceutical Services Business Overview
  118. 7.20.3 Aurigene Pharmaceutical Services Pharmaceutical Microbiology Testing Revenue and Gross Margin (2021-2026)
  119. 7.20.4 Aurigene Pharmaceutical Services Pharmaceutical Microbiology Testing Product Portfolio
  120. 7.20.5 Aurigene Pharmaceutical Services Recent Developments
  121. 7.21 Toray Research Center
  122. 7.21.1 Toray Research Center Company Information
  123. 7.21.2 Toray Research Center Business Overview
  124. 7.21.3 Toray Research Center Pharmaceutical Microbiology Testing Revenue and Gross Margin (2021-2026)
  125. 7.21.4 Toray Research Center Pharmaceutical Microbiology Testing Product Portfolio
  126. 7.21.5 Toray Research Center Recent Developments
  127. 7.22 Centre Testing International Group
  128. 7.22.1 Centre Testing International Group Company Information
  129. 7.22.2 Centre Testing International Group Business Overview
  130. 7.22.3 Centre Testing International Group Pharmaceutical Microbiology Testing Revenue and Gross Margin (2021-2026)
  131. 7.22.4 Centre Testing International Group Pharmaceutical Microbiology Testing Product Portfolio
  132. 7.22.5 Centre Testing International Group Recent Developments
  133. 7.23 Pony Testing International Group
  134. 7.23.1 Pony Testing International Group Company Information
  135. 7.23.2 Pony Testing International Group Business Overview
  136. 7.23.3 Pony Testing International Group Pharmaceutical Microbiology Testing Revenue and Gross Margin (2021-2026)
  137. 7.23.4 Pony Testing International Group Pharmaceutical Microbiology Testing Product Portfolio
  138. 7.23.5 Pony Testing International Group Recent Developments
  139. 7.24 Sumika Chemical Analysis Service
  140. 7.24.1 Sumika Chemical Analysis Service Company Information
  141. 7.24.2 Sumika Chemical Analysis Service Business Overview
  142. 7.24.3 Sumika Chemical Analysis Service Pharmaceutical Microbiology Testing Revenue and Gross Margin (2021-2026)
  143. 7.24.4 Sumika Chemical Analysis Service Pharmaceutical Microbiology Testing Product Portfolio
  144. 7.24.5 Sumika Chemical Analysis Service Recent Developments
  145. 7.25 CMIC Group
  146. 7.25.1 CMIC Group Company Information
  147. 7.25.2 CMIC Group Business Overview
  148. 7.25.3 CMIC Group Pharmaceutical Microbiology Testing Revenue and Gross Margin (2021-2026)
  149. 7.25.4 CMIC Group Pharmaceutical Microbiology Testing Product Portfolio
  150. 7.25.5 CMIC Group Recent Developments
  151. 7.26 LSI Medience
  152. 7.26.1 LSI Medience Company Information
  153. 7.26.2 LSI Medience Business Overview
  154. 7.26.3 LSI Medience Pharmaceutical Microbiology Testing Revenue and Gross Margin (2021-2026)
  155. 7.26.4 LSI Medience Pharmaceutical Microbiology Testing Product Portfolio
  156. 7.26.5 LSI Medience Recent Developments
8 North America
  1. 8.1 North America Pharmaceutical Microbiology Testing Revenue (2021-2032)
  2. 8.2 North America Pharmaceutical Microbiology Testing Revenue by Type (2021-2032)
  3. 8.2.1 North America Pharmaceutical Microbiology Testing Revenue by Type (2021-2026)
  4. 8.2.2 North America Pharmaceutical Microbiology Testing Revenue by Type (2027-2032)
  5. 8.3 North America Pharmaceutical Microbiology Testing Revenue Share by Type (2021-2032)
  6. 8.4 North America Pharmaceutical Microbiology Testing Revenue by Application (2021-2032)
  7. 8.4.1 North America Pharmaceutical Microbiology Testing Revenue by Application (2021-2026)
  8. 8.4.2 North America Pharmaceutical Microbiology Testing Revenue by Application (2027-2032)
  9. 8.5 North America Pharmaceutical Microbiology Testing Revenue Share by Application (2021-2032)
  10. 8.6 North America Pharmaceutical Microbiology Testing Revenue by Country
  11. 8.6.1 North America Pharmaceutical Microbiology Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Pharmaceutical Microbiology Testing Revenue by Country (2021-2026)
  13. 8.6.3 North America Pharmaceutical Microbiology Testing Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Pharmaceutical Microbiology Testing Revenue (2021-2032)
  2. 9.2 Europe Pharmaceutical Microbiology Testing Revenue by Type (2021-2032)
  3. 9.2.1 Europe Pharmaceutical Microbiology Testing Revenue by Type (2021-2026)
  4. 9.2.2 Europe Pharmaceutical Microbiology Testing Revenue by Type (2027-2032)
  5. 9.3 Europe Pharmaceutical Microbiology Testing Revenue Share by Type (2021-2032)
  6. 9.4 Europe Pharmaceutical Microbiology Testing Revenue by Application (2021-2032)
  7. 9.4.1 Europe Pharmaceutical Microbiology Testing Revenue by Application (2021-2026)
  8. 9.4.2 Europe Pharmaceutical Microbiology Testing Revenue by Application (2027-2032)
  9. 9.5 Europe Pharmaceutical Microbiology Testing Revenue Share by Application (2021-2032)
  10. 9.6 Europe Pharmaceutical Microbiology Testing Revenue by Country
  11. 9.6.1 Europe Pharmaceutical Microbiology Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Pharmaceutical Microbiology Testing Revenue by Country (2021-2026)
  13. 9.6.3 Europe Pharmaceutical Microbiology Testing Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Pharmaceutical Microbiology Testing Revenue (2021-2032)
  2. 10.2 China Pharmaceutical Microbiology Testing Revenue by Type (2021-2032)
  3. 10.2.1 China Pharmaceutical Microbiology Testing Revenue by Type (2021-2026)
  4. 10.2.2 China Pharmaceutical Microbiology Testing Revenue by Type (2027-2032)
  5. 10.3 China Pharmaceutical Microbiology Testing Revenue Share by Type (2021-2032)
  6. 10.4 China Pharmaceutical Microbiology Testing Revenue by Application (2021-2032)
  7. 10.4.1 China Pharmaceutical Microbiology Testing Revenue by Application (2021-2026)
  8. 10.4.2 China Pharmaceutical Microbiology Testing Revenue by Application (2027-2032)
  9. 10.5 China Pharmaceutical Microbiology Testing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pharmaceutical Microbiology Testing Revenue (2021-2032)
  2. 11.2 Asia Pharmaceutical Microbiology Testing Revenue by Type (2021-2032)
  3. 11.2.1 Asia Pharmaceutical Microbiology Testing Revenue by Type (2021-2026)
  4. 11.2.2 Asia Pharmaceutical Microbiology Testing Revenue by Type (2027-2032)
  5. 11.3 Asia Pharmaceutical Microbiology Testing Revenue Share by Type (2021-2032)
  6. 11.4 Asia Pharmaceutical Microbiology Testing Revenue by Application (2021-2032)
  7. 11.4.1 Asia Pharmaceutical Microbiology Testing Revenue by Application (2021-2026)
  8. 11.4.2 Asia Pharmaceutical Microbiology Testing Revenue by Application (2027-2032)
  9. 11.5 Asia Pharmaceutical Microbiology Testing Revenue Share by Application (2021-2032)
  10. 11.6 Asia Pharmaceutical Microbiology Testing Revenue by Country
  11. 11.6.1 Asia Pharmaceutical Microbiology Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Pharmaceutical Microbiology Testing Revenue by Country (2021-2026)
  13. 11.6.3 Asia Pharmaceutical Microbiology Testing Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pharmaceutical Microbiology Testing Revenue (2021-2032)
  2. 12.2 SAMEA Pharmaceutical Microbiology Testing Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Pharmaceutical Microbiology Testing Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Pharmaceutical Microbiology Testing Revenue by Type (2027-2032)
  5. 12.3 SAMEA Pharmaceutical Microbiology Testing Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Pharmaceutical Microbiology Testing Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Pharmaceutical Microbiology Testing Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Pharmaceutical Microbiology Testing Revenue by Application (2027-2032)
  9. 12.5 SAMEA Pharmaceutical Microbiology Testing Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Pharmaceutical Microbiology Testing Revenue by Country
  11. 12.6.1 SAMEA Pharmaceutical Microbiology Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Pharmaceutical Microbiology Testing Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Pharmaceutical Microbiology Testing Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst